BioLineRx (BLRX) Tops Q3 EPS by 4c
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.02), $0.04 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.02), $0.04 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.